According to Muri et al. [30], antibodies directed against COVID-19-associated markers such as CCL19, CCL22, and CXCL17 cluster together, and are sufficient on their own to correctly classify individuals as either uninfected controls or COVID-19 convalescents. The gene discussed is CCL19; the disease is COVID-19.